Effect of phenytoin on prenatal and postnatal development of rats

Biologia - Section Cellular and Molecular Biology

Volumn 55, Issue SUPPL. 8, 2000, Pages 125-130

  Ujházy, Eduard ^a   Dubovický, Michal ^a   Mach, Mojmír ^a   Juránek, Ivo ^a   Navarová, Jana ^a   Sadloňová, Irina ^b   Gajdošík, Andrej ^a  

^a INSTITUTE OF EXPERIMENTAL PHARMACOLOGY AND TOXICOLOGY   (Slovakia)

^b JSC   (Slovakia)

Author keywords

Behaviour; Intrauterine hypoxia; Offspring; Phenytoin; Rat; Teratogenicity

Indexed keywords

EID: 0345148543     PISSN: 13356399     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (20)

1. ADAMS, J. 1986. Methods in behavioral teratology, pp. 67-98. In: RILEY, E. P. & VORHEES, C. H. V. (eds) Handbook of Behavioral Teratology, Plenum Press, New York.
2. AZARBAYANI, F. & DANIELSSON, B. R. 1998. Pharmacologically induced embryonic dysrhythmia and episodes of hypoxia followed by reoxygenation: A common teratogenic mechanism for antiepileptic drugs? Teratology 57: 117-126.
3. COYLE, I. R. 1975. Changes in developing behaviour following prenatal administration of imipramine. Pharmacol. Biochem. Behav. 3: 799-807.
4. DANIELSSON, B. R. G., DANIELSSON, K. & REILAND, S. 1991. Distal limb defects caused by phenytoin: Relation to vascular disruption and hypoxia. Teratology 44: 26A.
5. DANIELSON, M. K., DANIELSSON, B. R.G., MARCHNER, H., LUNDIN, M., RUNDQUIST, E. & REILAND, S. 1992. Histopathological and hemodynamic studies supporting hypoxia and vascular disruption as explanation to phenytoin teratogenicity. Teratology 46: 485-497.
6. DANIELSSON, B. R., AZARBAYJANI, F., SKÖLD, A. C. & WEBSTER, W. S. 1997. Initiation of phenytoin teratogenesis: pharmacologically induced embryonic bradycardia and arrythmia resulting in hypoxia and possible free radical damage at reoxygenation. Teratology, 56: 271-281.
7. ELMAZAR, M. M. A. & SULLIVAN, F. M. 1981. Effect of prenatal phenytoin administration on postnatal development of the rat: A behavioral teratology study. Teratology 24: 115-124.
8. FERRAZZI, E., BULFAMANTE, G., MEZZOPANE, R., BARBERA, A., GHIDINI, A. & PARDI, G. 1999. Uterine Doppler velocimetry and placental hypoxic-ischemic lesion in pregnancies with fetal intrauterine growth restriction. Placenta 20: 389-394.
9. HARBISON, R. D. & BECKER, B. A. 1972. Diphenyl-hydantoin teratogenicity in rats. Toxicol. Appl. Pharmacol. 22: 193-200.
10. HASS, U., HANSEN, E. V., & OSTERGAARD, G. 1994. Postnatal and developmental neurotoxicity study - the need for OECD test guideline. Teratology 50: 34A.
11. CHRISTIANSE, C., RODBRO, P. & LUND, M. 1973. Effect of vitamin D on bone mineral mass in normal subjects and in epileptic patients on anticonvulsants. A controlled therapeutic trial. Br. Med. J. 2: 208-209.
12. KHERA, K. S. 1985. Maternal toxicity: a possible etiologic factor in embryo-fetal death and fetal malformations of rodent-rabbit species. Teratology 31: 129-136.
13. LORKE, D. 1977. Evaluation of skeleton, pp. 145-152. In: NEUBERT, D., MERKER, H.-J. & KWASIGROCH, D. (eds) Methods in Prenatal Toxicology, G. Thieme, Stuttgart.
14. MANSON, J. M. & KANG, Y. J. 1989. Test methods for assessing female reproductive and developmental toxicology, pp. 311-359. In: WALLACE HAYES, A. (ed) Principles and Methods in Toxicology, Raven Press, New York.
15. MASSEY, K. M. 1966. Teratogenic effects of diphenyl-hydantoin sodium. J. Oral. Ther. Pharmacol. 2: 380-385.
16. MCCARTNEY, M. A., SCINTO, P. L., WANG, S. S., & ALTMAN, S. 1999. Developmental effects of phenytoin may differ depending on the sex of offspring. Neurotoxicol. Teratol. 21: 119-128.
17. PELEG, D., KENNEDY, C. M. & HUNTER, S. K. 1998. Intrauterine growth restriction: identification and management. Am. Fam. Physician. 58: 453-460.
18. RONDO, P. H. & TOMKINS, A. M. 1999. Maternal iron status and intrauterine growth retardation. Trans. R. Soc. Trop. Med. Hyg. 93: 423-426.
19. VORHEES, C. V. 1987. Fetal hydantoin syndrome in rats: dose-effect relationship of prenatal phenytoin on postnatal development and behavior. Teratology 35: 287-303.
20. ZHU, M. X. 1989. Effect of diphenylhydantoin sodium in causing deformity and that of folic acid preparations for its prevention. Xenobiotica 12: 1471-1478.